“Innovative, easily applicable vaccine for poultry industry against five Salmonella serovars: Enteritidis, Typhimurium, Hadar, Virchow and Infantis – SAL ETHVI” (01.01-31.05.2016)

 

The aim of the project was to develop an innovative vaccine against salmonellosis in chickens — SalETHVI (Pat. PCT/IB2013/061054). The potential social benefits, innovation, and commercialization plan ensuring high profitability of SalETHVI implementation were recognized by the European Commission, resulting in the award of a grant under the “H2020-SMEINST-1-2015 Topic: SFS-08-2015-1 Type of action: SME-1 Proposal No.: 718558, Prop. Acron.: SAL ETHVI” support scheme.

Publications / conferences:

• Głośnicka R., Kościuk A., Bugajak P., Pułtorak A., Marczak M., Immunological properties of a vaccine for controlling salmonellosis in chickens. I. Serological response in chickens vaccinated per os with a preparation containing killed Salmonella bacteria and rabbit antibodies. https://immunolab.com.pl/wp-content/uploads/2012/05/Sal-ETHVI-publikacja-R.G.-M.M..pdf